Detection of SARS-Cov-2 N-protein in Mesenchymal Cells of Umbilical Warton's Jelly in Women with COVID-19

Article Sidebar

pdf (Русский) html (Русский) html
Published: Apr 30, 2022
DOI: https://doi.org/10.18097/BMCRM00165
Keywords:
SARS-Cov-2; placenta; umbilical cord; fibroblast-like cells

Main Article Content

N.V. Nizyaeva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia; Academician A.P. Avtsyn Research Institute of Human Morphology, Moscow, 117418 Russia
N.A. Lomova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia
E.L. Dolgopolova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia
T.E. Karapetyan
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia
U.L. Petrova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia
R.G. Shmakov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia
V.E. Frankevich
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4 bld. 2 Oparina str., Moscow, 117997 Russia

Abstract

Despite the large number of studies on the new coronavirus infection SARS-Cov-2 characterized by vascular damage on the impact of the virus on the mother-placenta-fetus system remains unknown. The umbilical cord, according to its functional purpose, is a complex of vessels protected from external influences by the embryonic connective tissue –Wharton's jelly. The aim of the study was to detect the structural components of SARS-Cov-2 in the histological structures of umbilicals cord in patients with COVID-19 in the tissues of the umbilical cord of women with COVID-19. The main group included 40 pregnant women who were treated at the academician V. I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (March-April 2020) with a confirmed diagnosis of COVID-19 (according to the positive PCR test of a nasopharyngeal swab) and 40 pregnant women of the comparison group, without clinical symptoms and laboratory tests, including the negative PCR test. As a result of the immunohistochemical study of the umbilical cord with primary antibodies to the SARS-Cov-2 N-protein in the COVID-19 group, staining of the cytoplasm of fibroblast-like cells and single macrophages Wharton's jelly was detected (p<0.05). In the group of women without coronavirus infection no staining in Wharton's jelly cells was detected. The probable persistence of viral particles in mesenchymal cells and macrophages of the Wharton's jelly in the umbilical cord can be important for establishment new aspects of influence COVID-19 on the mother-placenta-fetus system. Our results suggesting persistence of COVID-19 viral proteins in mesenchymal cells of the umbilical cord could be an important in establishing new pathogenic mechanisms for the fetal protection against viruses.

Article Details

How to Cite
Nizyaeva, N., Lomova, N., Dolgopolova, E., Karapetyan, T., Petrova, U., Shmakov, R., & Frankevich, V. (2022). Detection of SARS-Cov-2 N-protein in Mesenchymal Cells of Umbilical Warton’s Jelly in Women with COVID-19. Biomedical Chemistry: Research and Methods, 5(1), e00165. https://doi.org/10.18097/BMCRM00165
Issue
Vol. 5 No. 1 (2022)
Section
CLINICAL STUDIES

References

  1. Kovrigina, A.M., Shalamova, E.A., Berezovskij, Iy. S., (2020). Patomorfologicheskaya i immunogistoximicheskaya xarakteristika izmenenij limfaticheskix uzlov u umershix ot covid-19 po dannym autopsij. Klinicheskaya i Eksperimental'naya Morfologiya., 9(4), 12–23. DOI
  2. Atala, A., Henn, A., Lundberg, M. (2020). Regen med therapeutic opportunities for fighting COVID-19. Stem Cells Translational Med., 1, 5–13. DOI
  3. Becker, R.C. (2020). COVID-19-associated vasculitis and vasculopathy. J. Thromb Thrombolysis., 50(3), 499-511. DOI
  4. Lang, M., Som, A., Carey, D., et al. (2020). Pulmonary vascular manifestations of COVID-19 pneumonia. Radiol Cardiothorac Imaging., 2(3), e200277. DOI
  5. McGonagle, D., Bridgewood, C., Ramanan A.V., et al. (2021). COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol., 3(3), e224-e233. DOI
  6. Morris, D., Patel, K., Rahimi, O., et al. (2021). ANCA vasculitis: A manifestation of Post-Covid-19 Syndrome. Respir Med. Case Rep., 34, 101549. DOI
  7. Baergen, R. N. (2022). Benirschke’s Pathology of the Human Placenta. Springer Nature, 954 p.
  8. Lanzoni, G., Linetsky, E., Correa, D., et al. (2020). Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS). Cell R4 Repair Replace Regen Reprogram., 8, e2839. DOI
  9. Paladino, F.V., Rodrigues, J.M., Silva, A., Goldberg, A. C. (2019). The immunomodulatory potential of wharton's jelly mesenchymal stem/stromal cells. Stem Cells Int., 3548917. DOI
  10. Alanazi, A., (2021) COVID-19 and the role of stem cells. Regen Ther., 18, 334- 338. DOI
  11. Babal, P., Krivosikova, L., Sarvaicova, L., et al. (2021) Intrauterine fetal demise after uncomplicated COVID-19: What can we learn from the case? Viruses, 13(12), 2545. DOI
  12. Biringer, K., Sivakova, J., Marcinek, J., et al. (2021) Placental pathology concerning sudden fetal demise in SARS-CoV-2 positive asymptomatic pregnant female. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 165, 328-331. DOI
  13. Lesieur, E., Torrents, J., Fina, F., et al. (2021). Congenital infection of SARS- CoV-2 with intrauterine foetal death: a clinicopathological study with molecular analysis. Clin. Infect. Dis., ciab840. DOI
  14. Libbrecht, S., Van Cleemput, J., Vandekerckhove, L., et al. (2021) A rare but devastating cause of twin loss in a near-term pregnancy highlighting the features of severe SARS-CoV-2 placentitis. Histopathology, 79(4), 674-676. DOI
  15. Marinho, P.S., Cunha, A., Chimelli, L., et al. (2021) SARS-CoV-2 mother-to- child transmission and fetal death associated with severe placental thromboembolism. Front Med (Lausanne), 16(8), 677001. DOI
  16. Schwartz, D.A., Graham, A.L. (2020) Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses, 12(2), 194. DOI
  17. Vacchi, C., Meschiari, M., Milic, J., et al. (2020) COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford), 59(12), e147-e150. DOI
  18. Nizyaeva, N.V., Lomova, N.A., Dolgopolova, E.L,i dr. (2021) Vliyanie novoj koronavirusnoj infekcii COVID-19 na sistemu «mat'–placenta– plod». Vestnik RGMU, 2021(2), 27–34. DOI
  19. Gioia, C., Zullo, F., Vecchio, R. C., et al. (2022) Stillbirth and fetal capillary infection by SARS-CoV-2 632 Am. J. Obstet. Gynecol. MFM, 4(1), 100523. DOI
  20. Garrido-Pontnou, M., Navarro, A., Camacho, J., et al. (2021) Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associ-ated fetal demise. Mod. Pathol., 34, 1704-1709. DOI
  21. Marton, T., Hargitai, B., et al. (2021) Massive perivillous fibrin deposition and chronic histiocytic intervillositis a complication of SARS-CoV-2 Infection. Pediatr. Dev. Pathol., 24, 450-454. DOI
  22. Hosier, H., Farhadian, S. F., Morotti, R. A., at al. (2020) SARS–CoV-2 infection of the placenta. J. Clin. Invest., 130(9), 4947-4953. DOI
  23. Nagamatsu, T., Schust D. J. (2010) The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod. Sci., 17(3), 209-218. DOI
  24. Gurevich P.S. (2011) Immunopatologiya zarodyshevogo, `embrional'nogo i rannego fetal'nogo periodov cheloveka. Allogennye konflikty, Izrail', 182 p.
  25. Liu, W., Li, J. (2021) The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation. Viruses, 13(6), 1115. DOI
  26. Singh, D., Yi, S.V. (2021) On the origin and evolution of SARS-CoV-2. Exp. Mol. Med., 53, 537–547. DOI:10.1038/s12276-021-00604-z
  27. Uribe-Querol, E., Rosales, C. (2020) Phagocytosis: Our Current Understanding of a Universal Biological Process. Front Immunol., 11, 1066. DOI
  28. Beyerstedt, S., Casaro, E. B., Rangel, É. B. (2021) COVID-19: angiotensin- converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis., 40(5), 905-919. DOI
  29. Yang, J., Petitjean, S. J. L., Koehler, M., et al. (2021) Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat. Commun., 11(1), 4541. DOI
  30. Sukhacheva, T.V., Nizyaeva, N.V., Samsonova, M.V., et al. (2021) Morpho- functional changes of cardiac telocytes in isolated atrial amyloidosis in patients with atrial fibrillation. Sci Rep., 11, 3563. DOI
  31. Adukia, S. A., Ruhatiya, R. S., Maheshwarappa, H. M., et al. (2020) Extrapulmonary features of COVID-19: A Concise Review. Indian J. Crit. Care. Med., 24(7), 575-580. DOI:10.5005/jp-journals-10071-23476
  32. Elrobaal, I. H., New, K. J. (2021) COVID-19: Pulmonary and extra pulmonary manifestations. Front. Public Health, 9, 711616. DOI
  33. Gupta, A., Madhavan, M.V., Sehgal, K., et al. (2020) Extrapulmonary manifestations of COVID-19. Nat. Med., 26, 1017–1032. DOI
  34. Nasonov, E.L., Lila, A.M., Mazurov, V.I., et al. (2021) Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. recommendations of the association of rheumatologists of russia. rheumatology Science and Practice., 59(3), 239-254. DOI DOI